Thyroid Dyshormonogenesis 2A: Clinical Trials

1 trial for Thyroid Dyshormonogenesis 2A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow Thyroid Dyshormonogenesis 2A: new trials by email Literature Review of Thyroid Dyshormonogenesis 2A trials Research Report on Thyroid Dyshormonogenesis 2A

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
Aleeto - Multiple System Atrophy - Parkinsonian Subtype (MSA-P), Multiple System Atrophy, MSA
Early Phase 1RecruitingBeijing Tiantan Hospital202025-05-312025-09-03

Narrower conditions

Multiple System Atrophy (1)

Broader conditions

Autonomic Nervous System Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Primary Dysautonomias (1)  ·  Synucleinopathies (1)

Sponsors

Beijing Tiantan Hospital (1)

Countries

China (1)

Top investigators

Tao Feng, M.D. (1)  ·  Yilong Wang, M.D. (1)